Jonathan K. Cho, MD

Jonathan K. Cho, MD

This email address is being protected from spambots. You need JavaScript enabled to view it. | (808) 564-3999

Medical Director, Clinical Trials Office, University of Hawaiʻi Cancer Center

Academic Appointments:
Associate Professor, Translational and Clinical Research, University of Hawaiʻi Cancer Center

MD, John A. Burns School of Medicine, University of Hawaiʻi at Mānoa, Honolulu, Hawaiʻi
Internship, Internal Medicine, University of California, Irvine Medical Center, Orange, CA
Residency, Internal Medicine, University of California, Irvine Medical Center, Orange, CA
Fellowship, Medical Oncology, City of Hope National Medical Center, Duarte, CA
Fellowship, Hematology/Oncology, University of California, Irvine, Orange, CA

Diplomat, American Board of Internal Medicine
Diplomat, American Board of Internal Medicine, Medical Oncology

Professional Memberships

American College of Physicians
American Medical Association
American Society of Clinical Oncology
American Society of Hematology
Hawaiʻi Medical Association
Honolulu County Medical Society
International Association for the Study of Lung Cancer
Society of Neuro-Oncology

Research Focus

Dr. Cho is the Medical Director of the Clinical Trials Office (CTO). He previously served as the Principal Investigator (PI) of the NCI-funded Hawaiʻi Minority-Based Community Clinical Oncology Program (MBCCOP) at the University of Hawaiʻi Cancer Center. He has been a faculty member of the UH Cancer Center since 1991. Previously, while a practicing hematologist/oncologist in the community, he expanded the infrastructure of clinical trial activities at the UH Cancer Center, allowing for the conduct of both investigator-initiated translational research and pharmaceutical-sponsored trials. His role as medical director of the CTO is to expand and increase access to clinicals trials throughout the state of Hawaiʻi especially as it pertains to the Cancer Center’s 20By25 campaign. His efforts and research will be focused on overcoming the obstacles to participation in clinical trials especially as they relate to minority and underserved populations.

Selected Publications

Loh KP, Bao IR, Kleckner IR, PO JL, Cho JK, Mohile SG, et al. (2019). Effects of a Home-based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy. J Am Geriatr Soc; May; 67(5); 1005-1011.

Budd G, Barlow W, Moore H, Hobday T, Stewart J, Issacs C, Salim M, Cho J, Rinn K, Albain K, Chew H., Burton, G., Moore, t., Srkalovic, G., McGregor, B., Flaherty, L., Livington, R., Lew, D., Gralow J, Hortobagyl G. (2014). SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk, Early Stage Breast Cancer. J. of Clinical Oncology; 56-3296.

Cho JK. (2008). International Association for the Study of Lung Cancer - The Lung Cancer Staging Project, Hawai’i Med J; 67(8)220-222

Cho JK. (2003). Lung Cancer Treatment: Present and Future. Hawai’i Med J; 63(2):61-2.

Publication list via PubMed